Congressman Neguse is Selected for the Udall Public Service Award by the Michael J. Fox Foundation
Lafayette, CO—The Michael J Fox Foundation has awarded Congressman Joe Neguse with the Udall Award For Public Service for his ongoing work on pesticides and environmental protection. In the fall of 2020, Congressman Neguse introduced a comprehensive pesticide reform bill alongside Senator Tom Udall (D-NM) that, among many other things, would ban Paraquat, a chemical known to increase risk of Parkinson’s disease. The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson’s and improving therapies for those living with it, doing so with an ambitious research and legislative agenda.
You can read more about the award and its recipients here.
“The use of harmful pesticides on everything from our crops to our front yards has become all too commonplace, putting American farmworkers and young children at immense risk of harmful health impacts,” said Congressman Joe Neguse. “For far too long highly toxic pesticides have gone unregulated as the EPA has put the interests of the pesticide industry above the health and safety of people and our environment.”
Congressman Neguse has worked diligently to protect Americans from harmful substances since starting in Congress in 2019. Parkinson’s disease takes a significant economic and emotional toll on the United States, costing the economy $52 billion a year with over one million Americans living with the disease today.
The Udall Public Service Award is given to individuals who have made important contributions to public policy with humor, grace and dignity, in the spirit of Morris "Mo" K. Udall. Mo served in the House of Representatives for 30 years and was a candidate for the Democratic presidential nomination in 1976. During his career, he infused American politics with his singular style of humor, grace and dignity. Many of today's leaders — on both sides of the aisle — have cited Mo as a role model. He was diagnosed with Parkinson's in 1980 and died of complications from the disease in 1998.
Next Article Previous Article